Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certified Pharmacy Executive Leader
Digital Health & Informatics
Diversity, Equity and Inclusion
Health & Wellness
Opioids & Pain Management
Sterile Compounding
Favorite
Like
Facebook
Tweet
Print
Alexa Larson, PharmD
Poster(s):
(12-281) Assessment of Initial Heparin Dosing for Patients Presenting with Atrial Fibrillation, Unstable Angina, and Non-ST-Elevation Myocardial Infarction.
Wednesday, December 11, 2024
2:00 PM – 3:00 PM